Detalhe da pesquisa
1.
Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia.
Genes Dev
; 33(17-18): 1265-1279, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395741
2.
Signalling input from divergent pathways subverts B cell transformation.
Nature
; 583(7818): 845-851, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699415
3.
Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors.
Nature
; 558(7711): E5, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849140
4.
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Blood
; 138(16): 1465-1480, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077953
5.
Metabolic gatekeeper function of B-lymphoid transcription factors.
Nature
; 542(7642): 479-483, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192788
6.
Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.
Blood
; 129(9): 1155-1165, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031181
7.
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures.
Mol Syst Biol
; 13(2): 914, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202506
8.
B-cell lymphoblastic leukemia in an adolescent with Dravet syndrome.
Pediatr Blood Cancer
; 70(8): e30340, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073671
9.
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.
Nature
; 473(7347): 384-8, 2011 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21593872
10.
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.
Proc Natl Acad Sci U S A
; 111(21): E2219-28, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821775
11.
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.
Blood
; 121(1): 148-55, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152540
12.
Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
JCI Insight
; 8(23)2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906251
13.
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217248
14.
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.
Mol Cancer Ther
; 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064712
15.
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.
J Clin Invest
; 130(7): 3637-3653, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191635
16.
Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.
Nat Commun
; 8(1): 978, 2017 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29042531
17.
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
Cancer Cell
; 28(1): 114-28, 2015 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26073130
18.
Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
Cancer Cell
; 27(3): 409-25, 2015 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25759025
19.
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.
J Exp Med
; 210(4): 805-19, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478187
20.
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Nat Med
; 19(8): 1014-22, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23852341